Anthrogenesis Corporation

Celularity Inc.

Other

Qian Ye

James W Edinger

Robert J Hariri

Jia-Lun Wang

Mohit Bhatia

Chris Lugo

Jai-Lun Wang

Kristen S Labazzo

Herbert Faleck

Sascha Dawn Abramson

Andrew L Zeitlin

Mohammad A Heidaran

Uri Herzberg

Marian Pereira

RoseAnn Murray

Casper Paludan

Ryhor Harbacheuski

Colleen Delaney

Wolfgang Hofgartner

Aleksandr Kaplunovsky

Colleen Suzanne Dulaney

Mohit B Bhatia

Raihana Zaka

Jia-Iun Wang

Marian Periera

Provided herein are methods of treatment of individuals having an immune-related disease, disorder or condition, for example, inflammatory bowel disease, graft-versus-host disease, multiple sclerosis, rheumatoid arthritis, psoriasis, lupus erythematosus, diabetes, mycosis fungoides (Alibert-Bazin syndrome), or scleroderma using placental stem cells or umbilical cord stem cells.

Treatment of inflammatory diseases using placental stem cells

Provided herein are methods and compositions for the production of hepatocytes from placenta stem cells. Further provided herein is the use of such hepatocytes in the treatment of, and intervention in, for example, trauma, inflammation, and degenerative disorders of the liver. Also provided herein are compositions and methods relating to combinations of nanofibrous scaffolds and adherent placental stem cells and methods of using the same in cartilage repair. Finally, provided herein are compositions and methods relating to nonadherent, CD34CD45stem cells from placenta.

CD34,CD45placental stem cell-enriched cell populations

The present invention provides placental stem cells and placental stem cell populations, and methods of culturing, proliferating and expanding the same. The invention also provides methods of differentiating the placental stem cells. The invention further provides methods of using the placental stem cells in assays and for transplanting.

Placental stem cell populations

Provided herein are methods of using adherent placental stem cells and placental stem cell populations, and methods of culturing, proliferating and expanding the same. Also provided herein are methods of differentiating the placental stem cells. Further provided herein are methods of using the placental stem cells to formulate implantable or injectable compositions suitable for administration to a subject. Still further provided herein are provides methods for treating bone defects with stem cells and compositions comprising stem cells.

Methods and compositions for treatment of bone defects with placental cell populations

The present invention provides compositions comprising human placental telopeptide collagen, methods of preparing the compositions, methods of their use and kits comprising the compositions. The compositions, kits and methods are useful, for example, for augmenting or replacing tissue of a mammal.

Human placental collagen compositions, and methods of making and using the same

Provided herein are methods of evaluating potential antitumor compounds, and thereby identifying antitumor compounds, using placenta or a portion thereof and tumor cells, and compositions for accomplishing the same. In one embodiment, provided herein is a method of determining whether a potential antitumor compound is effective against a plurality of tumor cells, comprising introducing a plurality of tumor cells to, e.g., into or onto, a mammalian placenta or portion thereof; contacting said plurality of tumor cells for a period of time with said antitumor compound; and determining whether said antitumor compound is effective against said tumor cells, wherein said antitumor compound is effective against said tumor cells if said antitumor compound over said period of time reduces the number of said tumor cells or reduces the growth rate of said tumor cells.

Identification of antitumor compounds using placenta

Human placental collagen compositions and methods of making and using the same

Treatment of psoriasis using placental stem cells

Growing community of inventors

Livingston, NJ, United States of America

Qian Ye